Literature DB >> 25458698

Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli.

Nobuaki Ito1, Asiri R Wijenayaka1, Matthew Prideaux1, Masakazu Kogawa1, Renee T Ormsby1, Andreas Evdokiou2, Lynda F Bonewald3, David M Findlay1, Gerald J Atkins4.   

Abstract

Fibroblast growth factor-23 (FGF23), produced by osteocytes, is the key physiological regulator of phosphate homeostasis. Sepsis patients often experience transient hypophosphataemia, suggesting the regulation of FGF23 levels by pro-inflammatory factors. Here, we used the osteocyte-like cell line IDG-SW3 to investigate the effect of pro-inflammatory stimuli on FGF23 production. In differentiated IDG-SW3 cultures, basal Fgf23 mRNA was dose-dependently up-regulated by pro-inflammatory cytokines TNF, IL-1β and TWEAK, and bacterial LPS. Similar effects were observed in human bone samples. TNF- and IL-1β-induced Fgf23 expression was NF-κB-dependent. Conversely, mRNA encoding negative regulators of FGF23, Phex, Dmp1 and Enpp1, were suppressed by TNF, IL-1β, TWEAK and LPS, independent of NF-κβ signalling. Galnt3, the protein product of which protects intact FGF23 protein from furin/furin-like proprotein convertase cleavage, increased in response to these treatments. C-terminal FGF23 and intact FGF23 protein levels also increased, the latter only in the presence of Furin inhibitors, suggesting that enzymatic cleavage exerts critical control of active FGF23 secretion by osteocytes. Our results demonstrate in principle that pro-inflammatory stimuli are capable of increasing osteocyte secretion of FGF23, which may contribute to hypophosphataemia during sepsis and possibly other inflammatory conditions.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  FGF23; IL-1; LPS; Pro-inflammatory cytokines; TNF; TWEAK

Mesh:

Substances:

Year:  2014        PMID: 25458698     DOI: 10.1016/j.mce.2014.10.007

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  70 in total

Review 1.  Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.

Authors:  Marie Courbebaisse; Beate Lanske
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

2.  Proteinuria Is Associated With Increased Risk of Fragility Fracture in Men With or at Risk of HIV Infection.

Authors:  Anda Gonciulea; Ruibin Wang; Keri N Althoff; Michelle M Estrella; Deborah E Sellmeyer; Frank J Palella; Jordan E Lake; Lawrence A Kingsley; Todd T Brown
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

3.  Circulating FGF23 is not associated with cardiac dysfunction, atherosclerosis, infection or inflammation in hemodialysis patients.

Authors:  Yuichi Takashi; Shu Wakino; Hitoshi Minakuchi; Masashi Ishizu; Akio Kuroda; Hisato Shima; Manabu Tashiro; Keiko Miya; Kazuyoshi Okada; Jun Minakuchi; Shu Kawashima; Munehide Matsuhisa; Toshio Matsumoto; Seiji Fukumoto
Journal:  J Bone Miner Metab       Date:  2019-08-16       Impact factor: 2.626

Review 4.  Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.

Authors:  Evangelia Kalaitzoglou; Iuliana Popescu; R Clay Bunn; John L Fowlkes; Kathryn M Thrailkill
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

5.  A Novel Osteogenic Cell Line That Differentiates Into GFP-Tagged Osteocytes and Forms Mineral With a Bone-Like Lacunocanalicular Structure.

Authors:  Kun Wang; Lisa Le; Brad M Chun; LeAnn M Tiede-Lewis; Lora A Shiflett; Matthew Prideaux; Richard S Campos; Patricia A Veno; Yixia Xie; Vladimir Dusevich; Lynda F Bonewald; Sarah L Dallas
Journal:  J Bone Miner Res       Date:  2019-06-07       Impact factor: 6.741

Review 6.  Ironing out the cross talk between FGF23 and inflammation.

Authors:  Valentin David; Connor Francis; Jodie L Babitt
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-31

Review 7.  Non-renal-Related Mechanisms of FGF23 Pathophysiology.

Authors:  Mark R Hanudel; Marciana Laster; Isidro B Salusky
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

Review 8.  Inflammation regulates fibroblast growth factor 23 production.

Authors:  Connor Francis; Valentin David
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

9.  Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.

Authors:  Saurav Singh; Alexander Grabner; Christopher Yanucil; Karla Schramm; Brian Czaya; Stefanie Krick; Mark J Czaja; Rene Bartz; Reimar Abraham; Giovana S Di Marco; Marcus Brand; Myles Wolf; Christian Faul
Journal:  Kidney Int       Date:  2016-07-22       Impact factor: 10.612

10.  Systemic Control of Bone Homeostasis by FGF23 Signaling.

Authors:  Erica L Clinkenbeard; Kenneth E White
Journal:  Curr Mol Biol Rep       Date:  2016-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.